Jubilant Ingrevia Share Price -0.96% on Zettaone Technologies 40% Stake for Rs 189.2 Cr

Jubilant Ingrevia share price was down 0.96% to Rs 719.70 on 19 August 2026 despite the company announcing a binding agreement to acquire a 40% strategic stake in Zettaone Technologies India for Rs 189.2 crore. The Jubilant Ingrevia share price opened at Rs 732.45, touched an intraday high of Rs 737.00 before declining to a low of Rs 716.55. Volume was 1,29,786 shares, well below the average, indicating muted market response to the acquisition announcement.

Upon completion of the Zettaone acquisition, the technology company will become an associate company of Jubilant Ingrevia. A 40% stake acquisition makes Zettaone an associate rather than a subsidiary, meaning Jubilant Ingrevia will account for 40% of Zettaone's profits/losses under the equity method but will not fully consolidate its balance sheet. For the the stock, the key question is what capability or growth opportunity Zettaone brings to the specialty chemicals and life sciences business. The Nifty 50 was down 0.38% on 19 August, adding a mild market headwind to the Jubilant Ingrevia share price.

Click Here – Get Free Investment Predictions

Jubilant Ingrevia Share Price Key Data: 19 August 2026

Parameter	Data
Jubilant Ingrevia share price (LTP)	Rs 719.70
Change	-Rs 7.00 (-0.96%)
Intraday High	Rs 737.00
Intraday Low	Rs 716.55
Previous Close	Rs 726.70
Volume	1,29,786 shares
Zettaone Stake Acquired	40% strategic stake
Acquisition Cost	Rs 189.2 crore
Zettaone Status Post-Deal	Associate company of Jubilant Ingrevia

Jubilant Ingrevia share price as of 19 August 2026. Verify from NSE/BSE.

Zettaone Acquisition: What It Means for Jubilant Ingrevia Share Price

Technology Capability Building Through Associate Company Structure

Jubilant Ingrevia's choice to acquire a 40% stake rather than a controlling majority in Zettaone suggests a collaborative rather than acquisitive approach. As a 40% strategic shareholder, Jubilant Ingrevia can benefit from Zettaone's technology capabilities, integrate them into its specialty chemicals operations where relevant, and participate in Zettaone's growth, all without the capital and integration burden of a full acquisition. For the the stock, this structure limits financial risk while providing technological optionality.

Rs 189.2 Crore Investment: Context for Jubilant Ingrevia Share Price

For Jubilant Ingrevia, a company with annual revenues in the thousands of crores, a Rs 189.2 crore stake acquisition is a meaningful but not transformative investment. The key for the Jubilant Ingrevia share price is whether the Zettaone stake generates returns above the company's cost of capital within a reasonable timeframe. Strategic technology investments in the specialty chemicals sector can take 2-3 years to generate visible financial returns, and the market is likely to initially price this as a neutral to mildly dilutive event.

Track the stock and Specialty Chemicals Stocks on the Univest Screener

Conclusion

Jubilant Ingrevia share price fell 0.96% to Rs 719.70 on 19 August 2026 as the company announced a Rs 189.2 crore binding agreement to acquire a 40% strategic stake in Zettaone Technologies India. Upon completion, Zettaone will become an associate company of Jubilant Ingrevia. The Jubilant Ingrevia share price weakness reflects muted market enthusiasm for the acquisition amid broader market softness. Verify all data from NSE and BSE, and consult a SEBI-registered financial advisor before making investment decisions.

Download the Univest iOS App or Univest Android App to track the stock live and receive specialty chemicals sector research from Univest analysts.

Frequently Asked Questions on Jubilant Ingrevia Share Price

What is Jubilant Ingrevia share price today?

Ans. the stock is Rs 719.70, down 0.96% on 19 August 2026. The intraday high for the stock is Rs 737.00 and the intraday low is Rs 716.55. The previous close was Rs 726.70. Volume is 1,29,786 shares, well below the recent daily average of 41,804, suggesting low trading interest in the session despite the Zettaone acquisition announcement.

What is the Jubilant Ingrevia Zettaone Technologies acquisition?

Ans. Jubilant Ingrevia has entered into a binding agreement to acquire a 40% strategic stake in Zettaone Technologies India for Rs 189.2 crore. Upon completion of the acquisition, Zettaone Technologies will become an associate company of Jubilant Ingrevia. This is an equity stake investment, not a full acquisition; Zettaone will continue to operate as an independent entity with Jubilant Ingrevia as a 40% strategic shareholder.

What does Zettaone Technologies India do?

Ans. Zettaone Technologies India is a technology company whose specific business (likely in specialty chemicals, pharmaceutical tech, or industrial software given Jubilant Ingrevia's domain) will be detailed in official company disclosures. As a strategic acquisition by a specialty chemicals and life sciences company like Jubilant Ingrevia, Zettaone likely operates in areas like process technology, digital platforms for specialty chemical operations, or pharmaceutical innovation. Verify from the official Jubilant Ingrevia stock exchange filing.

Why did Jubilant Ingrevia acquire a stake in Zettaone Technologies?

Ans. Jubilant Ingrevia's 40% strategic acquisition of Zettaone Technologies for Rs 189.2 crore appears to be aimed at enhancing the company's technology capabilities or entering a new growth area adjacent to its core specialty chemicals and life sciences business. Strategic acquisitions of 40% stakes (making the target an associate company rather than a subsidiary) allow the acquirer to influence strategy and benefit from growth without fully consolidating all liabilities. The specific rationale will be detailed in Jubilant Ingrevia's stock exchange announcement.

Why is Jubilant Ingrevia share price down despite the acquisition?

Ans. the stock is down 0.96% on 19 August despite the Zettaone acquisition announcement, partly because a Rs 189.2 crore outflow for a minority stake can be viewed by some investors as a capital deployment event that reduces near-term free cash flow. If the strategic fit or the growth prospects of Zettaone are not immediately clear from the announcement, the market may react cautiously. Volume at 1,29,786 shares suggests limited conviction in either direction.

What does Jubilant Ingrevia do?

Ans. Jubilant Ingrevia is a specialty chemicals and life sciences company that manufactures chemical intermediates, nutritional ingredients, and specialty pharma products. The company's portfolio includes vitamin B3 (niacinamide), acetic anhydride, ethyl acetate, pyridine, and beta-picoline, which are used in pharmaceuticals, agriculture, and food industries. It is part of the Jubilant Bhartia Group.

Where can I track Jubilant Ingrevia share price live?

Ans. Track the stock live on NSE (nseindia.com) under ticker JUBLINGREA and on BSE (bseindia.com). The Univest app provides live the stock data, specialty chemicals sector research, and corporate action updates.